Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 268

1.

Controversies in iatrogenic bile duct injuries. Role of video-assisted laparoscopy in the management of iatrogenic bile duct injuries.

Pekolj J, Drago J.

Cir Esp. 2019 Aug 17. pii: S0009-739X(19)30201-5. doi: 10.1016/j.ciresp.2019.06.004. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
31431255
2.

Evaluation of the efficacy of lipotransfer to manage radiation-induced fibrosis and volume defects in head and neck oncology.

Griffin MF, Drago J, Almadori A, Kalavrezos N, Butler PE.

Head Neck. 2019 Oct;41(10):3647-3655. doi: 10.1002/hed.25888. Epub 2019 Aug 7.

PMID:
31389085
3.

FGFR1 Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor-Positive (HR+) Breast Cancer.

Drago JZ, Formisano L, Juric D, Niemierko A, Servetto A, Wander SA, Spring LM, Vidula N, Younger J, Peppercorn J, Yuen M, Malvarosa G, Sgroi D, Isakoff SJ, Moy B, Ellisen LW, Iafrate AJ, Arteaga CL, Bardia A.

Clin Cancer Res. 2019 Nov 1;25(21):6443-6451. doi: 10.1158/1078-0432.CCR-19-0138. Epub 2019 Aug 1.

PMID:
31371343
4.

Percutaneous Achilles tendon repair with the Dresden instrument. Clinical and MRI evaluation of 90 patients.

Joannas G, Arrondo G, Eslava S, Casola L, Drago J, Barousse R, Niño Gomez D, Amlang M, Rammelt S.

Foot Ankle Surg. 2019 Feb 25. pii: S1268-7731(18)30234-0. doi: 10.1016/j.fas.2019.02.005. [Epub ahead of print]

PMID:
30853390
5.

Targeting Apoptosis: A New Paradigm for the Treatment of Estrogen Receptor-Positive Breast Cancer.

Drago JZ, Chandarlapaty S, Jhaveri K.

Cancer Discov. 2019 Mar;9(3):323-325. doi: 10.1158/2159-8290.CD-19-0050.

PMID:
30824486
6.

Clinical experience with combination BRAF/MEK inhibitors for melanoma with brain metastases: a real-life multicenter study.

Drago JZ, Lawrence D, Livingstone E, Zimmer L, Chen T, Giobbie-Hurder A, Amann VC, Mangana J, Siano M, Zippelius A, Dummer R, Goldinger SM, Sullivan RJ.

Melanoma Res. 2019 Feb;29(1):65-69. doi: 10.1097/CMR.0000000000000527.

PMID:
30376465
7.

Gastric Schwannoma.

Drago J, Fuente I, Cavadas D, Beskow A, Wright F.

J Gastrointest Surg. 2019 Feb;23(2):381-383. doi: 10.1007/s11605-018-3926-3. Epub 2018 Aug 21. No abstract available.

PMID:
30132294
8.

The Harm in Kratom.

Drago JZ, Lane B, Kochav J, Chabner B.

Oncologist. 2017 Jul 24. pii: theoncologist.2017-0279. doi: 10.1634/theoncologist.2017-0279. [Epub ahead of print] No abstract available.

9.

Rapidly progressive Fronto-temporal dementia (FTD) associated with Frontotemporal lobar degeneration (FTLD) in the presence of Fused in Sarcoma (FUS) protein: a rare, sporadic, and aggressive form of FTD.

Bradfield NI, McLean C, Drago J, Darby DG, Ames D.

Int Psychogeriatr. 2017 Oct;29(10):1743-1746. doi: 10.1017/S1041610217001193. Epub 2017 Jun 29.

PMID:
28660843
10.

Motor and behavioral phenotype in conditional mutants with targeted ablation of cortical D1 dopamine receptor-expressing cells.

Jiang L, O'Leary C, Kim HA, Parish CL, Massalas J, Waddington JL, Ehrlich ME, Schütz G, Gantois I, Lawrence AJ, Drago J.

Neurobiol Dis. 2015 Apr;76:137-158. doi: 10.1016/j.nbd.2015.02.006. Epub 2015 Feb 12.

PMID:
25684539
11.

Prenatal nicotine exposure increases hyperventilation in α4-knock-out mice during mild asphyxia.

Avraam J, Cohen G, Drago J, Frappell PB.

Respir Physiol Neurobiol. 2015 Mar;208:29-36. doi: 10.1016/j.resp.2015.01.006. Epub 2015 Jan 14.

PMID:
25596543
12.

Role of α4- and α6-containing nicotinic receptors in the acquisition and maintenance of nicotine self-administration.

Madsen HB, Koghar HS, Pooters T, Massalas JS, Drago J, Lawrence AJ.

Addict Biol. 2015 May;20(3):500-12. doi: 10.1111/adb.12148. Epub 2014 Apr 22.

PMID:
24750355
13.

Resolving pathobiological mechanisms relating to Huntington disease: gait, balance, and involuntary movements in mice with targeted ablation of striatal D1 dopamine receptor cells.

Kim HA, Jiang L, Madsen H, Parish CL, Massalas J, Smardencas A, O'Leary C, Gantois I, O'Tuathaigh C, Waddington JL, Ehrlich ME, Lawrence AJ, Drago J.

Neurobiol Dis. 2014 Feb;62:323-37. doi: 10.1016/j.nbd.2013.09.015. Epub 2013 Oct 14.

PMID:
24135007
14.

Phenotyping dividing cells in mouse models of neurodegenerative basal ganglia diseases.

Smardencas A, Rizkalla K, Kim HA, Massalas J, O'Leary C, Ehrlich ME, Schütz G, Lawrence AJ, Drago J.

BMC Neurosci. 2013 Oct 3;14:111. doi: 10.1186/1471-2202-14-111.

15.

Evaluation of a modified community based care transitions model to reduce costs and improve outcomes.

Logue MD, Drago J.

BMC Geriatr. 2013 Sep 12;13:94. doi: 10.1186/1471-2318-13-94.

16.

Marchiafava-Bigmani disease in relation to pure alcohol consumption.

Sena P, Nzwalo H, Ferreira F, Drago J, Soleiro L.

J Neuropsychiatry Clin Neurosci. 2013 Spring;25(2):E71-2. doi: 10.1176/appi.neuropsych.12060153. No abstract available.

PMID:
23686077
17.

Behavioural and anatomical characterization of mutant mice with targeted deletion of D1 dopamine receptor-expressing cells: response to acute morphine.

Babovic D, Jiang L, Goto S, Gantois I, Schütz G, Lawrence AJ, Waddington JL, Drago J.

J Pharmacol Sci. 2013;121(1):39-47.

18.

Constitutive and conditional mutant mouse models for understanding dopaminergic regulation of orofacial movements: emerging insights and challenges.

Tomiyama K, Drago J, Waddington JL, Koshikawa N.

J Pharmacol Sci. 2012;119(4):297-301. Epub 2012 Jul 21. Review.

19.

Differential diagnosis in Alzheimer's disease and dementia with Lewy bodies via VMAT2 and amyloid imaging.

Villemagne VL, Okamura N, Pejoska S, Drago J, Mulligan RS, Chételat G, O'Keefe G, Jones G, Kung HF, Pontecorvo M, Masters CL, Skovronsky DM, Rowe CC.

Neurodegener Dis. 2012;10(1-4):161-5. doi: 10.1159/000334535. Epub 2012 Jan 17.

PMID:
22261520
20.

Automated assessment of bradykinesia and dyskinesia in Parkinson's disease.

Griffiths RI, Kotschet K, Arfon S, Xu ZM, Johnson W, Drago J, Evans A, Kempster P, Raghav S, Horne MK.

J Parkinsons Dis. 2012;2(1):47-55. doi: 10.3233/JPD-2012-11071.

PMID:
23939408
21.

In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease.

Villemagne VL, Okamura N, Pejoska S, Drago J, Mulligan RS, Chételat G, Ackermann U, O'Keefe G, Jones G, Gong S, Tochon-Danguy H, Kung HF, Masters CL, Skovronsky DM, Rowe CC.

Arch Neurol. 2011 Jul;68(7):905-12. doi: 10.1001/archneurol.2011.142.

PMID:
21747030
22.

Relation of addiction genes to hypothalamic gene changes subserving genesis and gratification of a classic instinct, sodium appetite.

Liedtke WB, McKinley MJ, Walker LL, Zhang H, Pfenning AR, Drago J, Hochendoner SJ, Hilton DL, Lawrence AJ, Denton DA.

Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12509-14. doi: 10.1073/pnas.1109199108. Epub 2011 Jul 11.

23.

The necessity of α4* nicotinic receptors in nicotine-driven behaviors: dissociation between reinforcing and motor effects of nicotine.

Cahir E, Pillidge K, Drago J, Lawrence AJ.

Neuropsychopharmacology. 2011 Jun;36(7):1505-17. doi: 10.1038/npp.2011.35. Epub 2011 Mar 23.

24.

Development of an in vitro model to evaluate the regenerative capacity of adult brain-derived tyrosine hydroxylase-expressing dopaminergic neurons.

Majd S, Smardencas A, Parish CL, Drago J.

Neurochem Res. 2011 Jun;36(6):967-77. doi: 10.1007/s11064-011-0435-0. Epub 2011 Mar 6.

PMID:
21380845
25.

Phenotypic disruption to orofacial movement topography in conditional mutants with generalized CamKIIa/Cre D1Tox versus striatal-specific DARPP-32/Cre D1Tox ablation of D1 dopamine receptor-expressing cells.

Tomiyama K, Kim HA, Kinsella A, Ehrlich ME, Schütz G, Koshikawa N, Lawrence AJ, Waddington JL, Drago J.

Synapse. 2011 Sep;65(9):835-42. doi: 10.1002/syn.20910. Epub 2011 Mar 10.

PMID:
21308794
26.

Creating a ventral midbrain stem cell niche in an animal model for Parkinson's disease.

Fernando CV, Moses D, Parish CL, Tomas D, Drago J, Horne MK.

Stem Cells Dev. 2010 Dec;19(12):1995-2007. doi: 10.1089/scd.2009.0486. Epub 2010 Aug 12.

PMID:
20415529
27.

In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133.

Okamura N, Villemagne VL, Drago J, Pejoska S, Dhamija RK, Mulligan RS, Ellis JR, Ackermann U, O'Keefe G, Jones G, Kung HF, Pontecorvo MJ, Skovronsky D, Rowe CC.

J Nucl Med. 2010 Feb;51(2):223-8. doi: 10.2967/jnumed.109.070094. Epub 2010 Jan 15.

28.

Age-related behavioural phenotype and cellular characterisation of mice with progressive ablation of D1 dopamine receptor-expressing cells.

Babovic D, Jiang L, Gantois I, Lawrence AJ, Ferreri V, Schütz G, Waddington JL, Drago J.

Behav Brain Res. 2010 Jan 5;206(1):78-87. doi: 10.1016/j.bbr.2009.08.036. Epub 2009 Sep 4.

PMID:
19733597
29.

Altered fast- and slow-twitch muscle fibre characteristics in female mice with a (S248F) knock-in mutation of the brain neuronal nicotinic acetylcholine receptor.

Cannata DJ, Finkelstein DI, Gantois I, Teper Y, Drago J, West JM.

J Muscle Res Cell Motil. 2009;30(1-2):73-83. doi: 10.1007/s10974-009-9177-x. Epub 2009 Apr 29.

PMID:
19404753
30.

SK channel function regulates the dopamine phenotype of neurons in the substantia nigra pars compacta.

Aumann TD, Gantois I, Egan K, Vais A, Tomas D, Drago J, Horne MK.

Exp Neurol. 2008 Oct;213(2):419-30. doi: 10.1016/j.expneurol.2008.07.005. Epub 2008 Jul 15.

PMID:
18680743
31.

Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia.

Lee J, Zhu WM, Stanic D, Finkelstein DI, Horne MH, Henderson J, Lawrence AJ, O'Connor L, Tomas D, Drago J, Horne MK.

Brain. 2008 Jun;131(Pt 6):1574-87. doi: 10.1093/brain/awn085. Epub 2008 May 16.

PMID:
18487277
32.

Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo.

Moses D, Drago J, Teper Y, Gantois I, Finkelstein DI, Horne MK.

Neuroscience. 2008 Jun 23;154(2):606-20. doi: 10.1016/j.neuroscience.2008.03.058. Epub 2008 Apr 8.

PMID:
18472226
33.

Quantified assessment of terminal density and innervation.

Finkelstein DI, Stanic D, Parish CL, Drago J, Horne MK.

Curr Protoc Neurosci. 2004 Sep;Chapter 1:Unit 1.13. doi: 10.1002/0471142301.ns0113s27.

PMID:
18428595
34.

Dopamine D1 vs D5 receptor-dependent induction of seizures in relation to DARPP-32, ERK1/2 and GluR1-AMPA signalling.

O'Sullivan GJ, Dunleavy M, Hakansson K, Clementi M, Kinsella A, Croke DT, Drago J, Fienberg AA, Greengard P, Sibley DR, Fisone G, Henshall DC, Waddington JL.

Neuropharmacology. 2008 Jun;54(7):1051-61. doi: 10.1016/j.neuropharm.2008.02.011. Epub 2008 Feb 21.

35.

Nicotine-induced dystonic arousal complex in a mouse line harboring a human autosomal-dominant nocturnal frontal lobe epilepsy mutation.

Teper Y, Whyte D, Cahir E, Lester HA, Grady SR, Marks MJ, Cohen BN, Fonck C, McClure-Begley T, McIntosh JM, Labarca C, Lawrence A, Chen F, Gantois I, Davies PJ, Petrou S, Murphy M, Waddington J, Horne MK, Berkovic SF, Drago J.

J Neurosci. 2007 Sep 19;27(38):10128-42.

37.

Ablation of D1 dopamine receptor-expressing cells generates mice with seizures, dystonia, hyperactivity, and impaired oral behavior.

Gantois I, Fang K, Jiang L, Babovic D, Lawrence AJ, Ferreri V, Teper Y, Jupp B, Ziebell J, Morganti-Kossmann CM, O'Brien TJ, Nally R, Schütz G, Waddington J, Egan GF, Drago J.

Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4182-7. Epub 2007 Feb 28.

38.

Null mutation of the alpha4 nicotinic receptor subunit increases the propensity of muscarinic-mediated neuronal bursting in mouse hippocampal slices.

Reid CA, Coleman HA, Finkelstein DI, Horne MK, Drago J.

Neuropharmacology. 2006 Sep;51(3):587-96. Epub 2006 Jun 23.

PMID:
16806302
39.

Murine embryonic EGF-responsive ventral mesencephalic neurospheres display distinct regional specification and promote survival of dopaminergic neurons.

Moses D, Teper Y, Gantois I, Finkelstein DI, Horne MK, Drago J.

Exp Neurol. 2006 May;199(1):209-21. Epub 2006 Apr 19.

PMID:
16626706
40.
41.

Genetic interdependence of adenosine and dopamine receptors: evidence from receptor knockout mice.

Short JL, Ledent C, Borrelli E, Drago J, Lawrence AJ.

Neuroscience. 2006 May 12;139(2):661-70. Epub 2006 Feb 14.

PMID:
16476524
42.

Receptor crosstalk: characterization of mice deficient in dopamine D1 and adenosine A2A receptors.

Short JL, Ledent C, Drago J, Lawrence AJ.

Neuropsychopharmacology. 2006 Mar;31(3):525-34.

43.

Mice lacking the alpha4 nicotinic receptor subunit fail to modulate dopaminergic neuronal arbors and possess impaired dopamine transporter function.

Parish CL, Nunan J, Finkelstein DI, McNamara FN, Wong JY, Waddington JL, Brown RM, Lawrence AJ, Horne MK, Drago J.

Mol Pharmacol. 2005 Nov;68(5):1376-86. Epub 2005 Aug 2.

PMID:
16077034
44.

Assessment of temperature, proximity, and course of the esophagus during radiofrequency ablation within the left atrium.

Cummings JE, Schweikert RA, Saliba WI, Burkhardt JD, Brachmann J, Gunther J, Schibgilla V, Verma A, Dery M, Drago JL, Kilicaslan F, Natale A.

Circulation. 2005 Jul 26;112(4):459-64. Epub 2005 Jul 18.

PMID:
16027254
45.

Alternative energy sources for the ablation of arrhythmias.

Cummings JE, Pacifico A, Drago JL, Kilicaslan F, Natale A.

Pacing Clin Electrophysiol. 2005 May;28(5):434-43. Review. No abstract available.

PMID:
15869678
46.

Haloperidol treatment reverses behavioural and anatomical changes in cocaine-dependent mice.

Parish CL, Drago J, Stanic D, Borrelli E, Finkelstein DI, Horne MK.

Neurobiol Dis. 2005 Jun-Jul;19(1-2):301-11.

PMID:
15837586
47.

Gustatory stimulation influences the processing of intranasal stimuli.

Welge-Lüssen A, Drago J, Wolfensberger M, Hummel T.

Brain Res. 2005 Mar 15;1038(1):69-75.

PMID:
15748874
48.

D1-like dopamine receptor-mediated function in congenic mutants with D1 vs. D5 receptor "knockout".

O'Sullivan GJ, Clifford JJ, Tomiyama K, Koshikawa N, Drago J, Sibley DR, Croke DT, Waddington JL.

J Recept Signal Transduct Res. 2004 Aug;24(3):107-16.

PMID:
15521357
49.

Glial responses associated with dopaminergic striatal reinnervation following lesions of the rat substantia nigra.

Stanic D, Tripanichkul W, Drago J, Finkelstein DI, Horne MK.

Brain Res. 2004 Oct 8;1023(1):83-91.

PMID:
15364022
50.

Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice.

Kobayashi M, Iaccarino C, Saiardi A, Heidt V, Bozzi Y, Picetti R, Vitale C, Westphal H, Drago J, Borrelli E.

Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11465-70. Epub 2004 Jul 22.

Supplemental Content

Support Center